MedTrace Logo

VR-Assisted Rehabilitation in Partial Supraspinatus Tears

NCT07478835 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2026-03-23

No results posted yet for this study

Summary

This randomized controlled trial aims to investigate the effects of virtual reality-assisted rehabilitation in patients with partial supraspinatus tendon tears. Virtual reality has emerged as a promising tool to enhance patient engagement and improve rehabilitation outcomes in musculoskeletal disorders; however, evidence in this patient population remains limited. Participants will be assigned to either a virtual reality-assisted rehabilitation group or a conventional rehabilitation group. Both groups will receive a structured physical therapy program, while the intervention group will additionally perform virtual reality-based exercises. The study will evaluate the potential benefits of virtual reality in improving clinical outcomes compared to conventional rehabilitation.

Conditions

  • Partial Supraspinatus Tear
  • Shoulder Pain

Interventions

BEHAVIORAL

VR-assisted rehabilitation program

Participants in the experimental group received the same conventional physiotherapy program as the control group and additionally performed virtual reality (VR)-assisted exercises. A Meta Quest Pro VR headset (Meta Platforms Inc.) was used to provide an immersive virtual environment during the intervention. The system provides high-resolution optics, a wide field of view, and six degrees of freedom (6DoF) motion tracking, allowing accurate tracking of upper extremity movements. VR-based exercises were designed to promote repetitive shoulder and upper limb movements through interactive, task-oriented activities within a three-dimensional virtual environment.

BEHAVIORAL

Conventional shoulder exercise program

After completion of the standard physiotherapy modalities, participants performed a set of therapeutic exercises aimed at improving shoulder mobility and coordination of the shoulder girdle muscles

Sponsors & Collaborators

  • Hitit University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-12-20
Completion
2025-12-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07478835 on ClinicalTrials.gov